Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL31P57 is a processed pseudogene for ribosomal protein L31, located in the human genome. Unlike the functional RPL31 gene, RPL31P57 does not encode an active protein and does not participate directly in ribosome structure or catalysis. Ribosomal protein pseudogenes like RPL31P57 may have regulatory functions at the RNA level, such as acting as endogenous competitive RNAs (ceRNAs) or providing short interfering RNAs that modulate the parent gene’s expression. These regulatory activities are observed under stress and neuropsychiatric conditions, where pseudogene expression can be upregulated, potentially affecting the protein synthesis machinery and synaptic plasticity. RPL31P57 itself is not used as a therapeutic target, does not code for a functional protein, and is not used as a biomarker for disease monitoring[1][2][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 57 (RPL31P57).